ISRCTN43430382
Completed
未知
Controlled ovarian stimulation and intrauterine insemination or in vitro fertilization for the first line treatment of unexplained infertility: a randomised controlled trial
Homerton University Hospital (UK)0 sites320 target enrollmentAugust 8, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Infertility
- Sponsor
- Homerton University Hospital (UK)
- Enrollment
- 320
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Couples with female partner's age between 23\- 37 years
- •2\. Diagnosed with unexplained infertility at the time of first treatment
- •3\. Inability to conceive following a minimum of one year of unprotected intercourse
- •4\. In the presence of normal semen analysis, proof of regular ovulatory cycles with a day 3 follicle stimulating hormone (FSH)\<10IU/L
- •5\. Two patent tubes and a normal uterine cavity on hysterosalpingography (HSG)
Exclusion Criteria
- •1\. Female partner aged 37 years or more
- •2\. People with physical disability or psychosexual problems who find difficulty in achieving vaginal intercourse
- •3\. Couples in a same sex relationship (as these do not fall into the definition of unexplained infertility)
- •4\. Couples where the male/female is HIV positive, as they would need specific consideration to methods of conception
- •5\. Couples who have had no previous IUI or IVF treatment for infertility
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOSIRCT201109163386N4Semnan University of Medical Sciences142
Active, not recruiting
Phase 1
Comparison of the difference in the number of oocytes obtained by administering the ovarian stimulation treatment as usually with administering it only once and later.EUCTR2019-001343-44-ESInstituto Bernabeu180
Completed
Phase 2
Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.IRCT201701291952N8Vice Chancellor for research, Tehran University of Medical Science160
Completed
Phase 2
Investigating the effectiveness of intraovarian injection of platelet rich plasma on ovarian reserve in infertile women due to decreased ovarian reserveIRCT20160722029027N14Shahid Beheshti University of Medical Sciences15
Not yet recruiting
Phase 3
Investigating the effect of intraovarian administration of platelet rich plasma in patients with poor ovarian response in improving the result of assisted proceduresReducedovarian reserve..Primary ovarian failureE28.3IRCT20200905048630N5Bandare-abbas University of Medical Sciences88